Movement Alert｜QingSong Health Rises 8.49% in Regular Trading, Multiple Catalysts Including Full CAICT Certification Boost Sentiment

Market Focus07-16

On July 16, QingSong Health rose 8.49% in regular trading, trading at HKD 7.74/share, with turnover of HKD 132 million.

The rally was driven by a convergence of recent positive developments. The company's core AI product MedClaw has passed the China Academy of Information and Communications Technology (CAICT) full 13-dimension certification, with three capabilities receiving the only full-score rating in the assessment, reinforcing its credibility in the medical AI space.

Supporting the upward momentum, the company has been actively executing its previously announced HKD 100 million share buyback program, having repurchased over 5 million shares to date. Controlling shareholder Yang Yin also voluntarily extended her lock-up period to early next year, signaling confidence in the company's trajectory. Additionally, QingSong Health recently announced strategic partnerships with Alibaba Cloud and Chinese Online to strengthen its AI infrastructure from both computing power and data dimensions, while launching the evidence-based medical recording device ZhengYin at the China Internet Conference.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1152079350?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 14:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152079350","market":"us","top_or_hot":-1,"title":"Movement Alert｜QingSong Health Rises 8.49% in Regular Trading, Multiple Catalysts Including Full CAICT Certification Boost Sentiment","media":"Market Focus","content":"<p><p>On July 16, QingSong Health rose 8.49% in regular trading, trading at HKD 7.74/share, with turnover of HKD 132 million.</p><p>The rally was driven by a convergence of recent positive developments. The company's core AI product MedClaw has passed the China Academy of Information and Communications Technology (CAICT) full 13-dimension certification, with three capabilities receiving the only full-score rating in the assessment, reinforcing its credibility in the medical AI space.</p><p>Supporting the upward momentum, the company has been actively executing its previously announced HKD 100 million share buyback program, having repurchased over 5 million shares to date. Controlling shareholder Yang Yin also voluntarily extended her lock-up period to early next year, signaling confidence in the company's trajectory. Additionally, QingSong Health recently announced strategic partnerships with Alibaba Cloud and Chinese Online to strengthen its AI infrastructure from both computing power and data dimensions, while launching the evidence-based medical recording device ZhengYin at the China Internet Conference.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜QingSong Health Rises 8.49% in Regular Trading, Multiple Catalysts Including Full CAICT Certification Boost Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜QingSong Health Rises 8.49% in Regular Trading, Multiple Catalysts Including Full CAICT Certification Boost Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-16 14:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 16, QingSong Health rose 8.49% in regular trading, trading at HKD 7.74/share, with turnover of HKD 132 million.</p><p>The rally was driven by a convergence of recent positive developments. The company's core AI product MedClaw has passed the China Academy of Information and Communications Technology (CAICT) full 13-dimension certification, with three capabilities receiving the only full-score rating in the assessment, reinforcing its credibility in the medical AI space.</p><p>Supporting the upward momentum, the company has been actively executing its previously announced HKD 100 million share buyback program, having repurchased over 5 million shares to date. Controlling shareholder Yang Yin also voluntarily extended her lock-up period to early next year, signaling confidence in the company's trajectory. Additionally, QingSong Health recently announced strategic partnerships with Alibaba Cloud and Chinese Online to strengthen its AI infrastructure from both computing power and data dimensions, while launching the evidence-based medical recording device ZhengYin at the China Internet Conference.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02661","symbol_name":"轻松健康","start_time":0,"source_url":"","article_id":"1152079350","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152079350","pubTimestamp":1784184429,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 16, QingSong Health rose 8.49% in regular trading, trading at HKD 7.74/share, with turnover of HKD 132 million.The rally was driven by a convergence of recent positive developments. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02661":"轻松健康"},"translate_title":"走势提醒|青松健康常规交易涨8.49%，CAICT全面认证等多重催化剂提振人气","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02661":1},"content_text":"On July 16, QingSong Health rose 8.49% in regular trading, trading at HKD 7.74/share, with turnover of HKD 132 million.The rally was driven by a convergence of recent positive developments. The company's core AI product MedClaw has passed the China Academy of Information and Communications Technology (CAICT) full 13-dimension certification, with three capabilities receiving the only full-score rating in the assessment, reinforcing its credibility in the medical AI space.Supporting the upward momentum, the company has been actively executing its previously announced HKD 100 million share buyback program, having repurchased over 5 million shares to date. Controlling shareholder Yang Yin also voluntarily extended her lock-up period to early next year, signaling confidence in the company's trajectory. Additionally, QingSong Health recently announced strategic partnerships with Alibaba Cloud and Chinese Online to strengthen its AI infrastructure from both computing power and data dimensions, while launching the evidence-based medical recording device ZhengYin at the China Internet Conference.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1152079350","isCrawlerRequest":true}